Heron Therapeutics is a biotech company with its headquarters located in San Diego, California. They mainly focus on developing treatments to treat unmet patient needs by utilizing their proprietary Biochronomer drug delivery technology that distributes therapeutic levels of short-acting pharmacological agents over a period of days to weeks with just a single administration. Their products such as SUSTOL, CINVANTI, ZYNRELEF, HTX-019, and HTX-034, are dedicated to addressing various medical concerns such as pain relief, nausea, and vomiting associated with cancer chemotherapy and postoperative recovery.